NCT00712478已完成不适用
Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 114
- 主要终点
- Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements
研究概览
简要总结
This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes patients
- •Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
- •HbA1c greater than or equal to 8.0%
排除标准
- •Patients not performing glycaemia self-measurements
- •Secondary diabetes
- •Requirement of or use of an insulin pump
- •Treatment with corticoids
研究组 & 干预措施
A
干预措施: insulin (Drug)
结局指标
主要结局
Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements
时间窗: After 3 months
次要结局
- Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements(After first 2 months)
研究者
相似试验
已完成
不适用
Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlDiabetesDiabetes Mellitus, Type 2NCT00700960Novo Nordisk A/S2,745
已完成
不适用
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00676741Novo Nordisk A/S3,809
已完成
不适用
Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 MonthsDiabetesDiabetes Mellitus, Type 2NCT00755833Novo Nordisk A/S270
已完成
不适用
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00670722Novo Nordisk A/S6,500
已完成
不适用
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01288326Novo Nordisk A/S254
